ORIGINAL ARTICLE

Policy and programmatic considerations for introducing a longer-acting injectable contraceptive: perspectives of stakeholders from Kenya and Rwanda

Kevin McKenna, Jennet Arcara, Kate H Rademacher, Caroline Mackenzie, Fidele Ngabo, Emmanuel Munyambanza, Jennifer Wesson and Elizabeth E Tolley
Global Health: Science and Practice December 2014, 2(4):459-471; https://doi.org/10.9745/GHSP-D-14-00106
Submit a Comment to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

No comments have been published for this article.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Policy and programmatic considerations for introducing a longer-acting injectable contraceptive: perspectives of stakeholders from Kenya and Rwanda
Kevin McKenna, Jennet Arcara, Kate H Rademacher, Caroline Mackenzie, Fidele Ngabo, Emmanuel Munyambanza, Jennifer Wesson, Elizabeth E Tolley
Global Health: Science and Practice Dec 2014, 2 (4) 459-471; DOI: 10.9745/GHSP-D-14-00106
del.icio.us logo Twitter logo Facebook logo Mendeley logo

Statistics from Altmetric.com

Jump to section

Subjects